Marta Barrachina



  1. Villar Menéndez I, Díaz Sánchez S, Blanch M, Albasanz J, Pereira Veiga T, Monje A, et al. Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia. J Psychiatr Res. 2014;51:49-59 pubmed publisher
    ..Therefore, there may be a subgroup of SZ patients with reduced striatal A2AR levels accompanied by an altered motor phenotype. ..
  2. Blanch M, Mosquera J, Ansoleaga B, Ferrer I, Barrachina M. Altered Mitochondrial DNA Methylation Pattern in Alzheimer Disease-Related Pathology and in Parkinson Disease. Am J Pathol. 2016;186:385-97 pubmed publisher
    ..In summary, the present findings suggest mtDNA epigenetic modulation in human brain is vulnerable to neurodegenerative disease states. ..
  3. Villar Menéndez I, Porta S, Buira S, Pereira Veiga T, Díaz Sánchez S, Albasanz J, et al. Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b. Neurobiol Dis. 2014;69:206-14 pubmed publisher